Clinical Feasibility of Six Inflammatory Markers for Predicting the Mortality of Patients With Cancer: Longitudinal Study
JMIR Cancer · 22.07.2026 · 12 · e99410-e99410
DOI: 10.2196/99410 ↗Kurz gefasst
Fachartikel in der Zeitschrift JMIR Cancer, online erschienen am 22.07.2026. Verfasst von Kangwei Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Affiliated Yueqing Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Neoplasms, Inflammation, Biomarkers, Tumor. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Emerging evidence indicates that inflammation plays a crucial role in cancer prognosis. Inflammatory response biomarkers are recognized as promising prognostic factors for mortality in patients with cancer.
Objective
This study aims to evaluate the prognostic significance of the systemic inflammatory response index (SIRI), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), inflammatory prognostic index (IPI), and C-reactive protein-albumin-lymphocyte (CALLY) index.
Methods
Weighted Cox regression analyses, restricted cubic spline models, Kaplan-Meier survival curves, and receiver operating characteristic analyses were performed to assess the predictive value of the 6 inflammatory markers for mortality. Subgroup analyses and sensitivity analyses were conducted to examine associations within specific subpopulations.
Results
Cox regression models demonstrated that SIRI, NLR, IPI, and CALLY were significant predictors of all-cause mortality (tertile 3 vs tertile 1; hazard ratio [HR]: SIRI: 1.72, 95% CI 1.29‐2.27; NLR: 1.33, 95% CI 1.02‐1.74; IPI: 1.48, 95% CI 1.14‐1.92; CALLY: 0.66, 95% CI 0.51‐0.85). IPI (HR 1.91, 95% CI 1.11‐3.27) and CALLY (HR 0.53, 95% CI 0.31‐0.90) were significantly associated with cancer-specific mortality, whereas only SIRI was able to predict cardiovascular mortality ( P value for trend=.04). Dose-response relationships were observed between the 6 inflammatory markers and mortality outcomes. Kaplan-Meier survival curves further illustrated significant differences between tertile groups (log-rank test, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Affiliated Yueqing Hospital of Wenzhou Medical University, Wenzhou, China.
- School of Digital Economics, Wenzhou Vocational College of Science and Technology, Wenzhou, China.
- Department of Infectious Diseases, Wenzhou Central Hospital, Wenzhou, China.
- Department of Infectious Diseases, Wenzhou Sixth People's Hospital, Wenzhou, China.
- Wenzhou Key Laboratory of Diagnosis and Treatment of Emerging and Recurrent Infectious Diseases, Wenzhou, China.
- MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Nanbaixiang Street, Ouhai District, Wenzhou, 325000, China, 86 15057503329.
ORCID-Profile: Kangwei Wang, Ce Shi, Dingchao Xia, Ya Lin
Zitieren
APA
Wang, K., Shi, C., Xia, D., & Lin, Y. (2026). Clinical Feasibility of Six Inflammatory Markers for Predicting the Mortality of Patients With Cancer: Longitudinal Study. JMIR Cancer, 12, e99410-e99410. https://doi.org/10.2196/99410
Vancouver
Wang K, Shi C, Xia D, Lin Y. Clinical Feasibility of Six Inflammatory Markers for Predicting the Mortality of Patients With Cancer: Longitudinal Study. JMIR Cancer. 2026;12:e99410-e99410. doi:10.2196/99410
BibTeX
@article{Wang2026,
author = {Wang, Kangwei and Shi, Ce and Xia, Dingchao and Lin, Ya},
title = {Clinical Feasibility of Six Inflammatory Markers for Predicting the Mortality of Patients With Cancer: Longitudinal Study},
journal = {JMIR Cancer},
year = {2026},
volume = {12},
pages = {e99410--e99410},
doi = {10.2196/99410}
}
EUVIMED